GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome ...
1 day ago · The FDA on Tuesday required GSK and Pfizer to include warnings about Guillain-Barré syndrome risk in the labels for their respiratory syncytial virus vaccines.. The directive follows a post-marketing study by the regulator, which found that patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo are at greater risks of developing GBS, a rare neurological disorder characterized by ...
GSK, Pfizer RSV shots must warn about rare paralysis risk
1 day ago · Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. Photo by Beata Zawrzel/NurPhoto via Getty Images Rankings
GSK, Pfizer RSV Shots to Warn About Rare Neurological Disorder
2 days ago · GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased risk of a rare neurological side effect that can lead to paralysis ...
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
4 days ago · GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer.
Look out GSK, Pfizer and BioNTech are coming for Shingrix
2 days ago · GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a...
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
Aug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with …
Pfizer seeks to overturn three RSV vaccine patents held by GSK
5 days ago · GSK's vaccine has just hit the mark in a phase 3 trial, and the company is preparing regulatory filings seeking approval for use in older adults in an attempt to stay ahead of Pfizer and...
Pfizer to exit GSK consumer health joint venture after spinoff
Jun 1, 2022 · GSK will put at least 80% of its 68% holding in the joint venture into Haleon, which is set to begin trading on the London Stock Exchange on July 18. Pfizer currently owns the other 32% and will exit the business “in a disciplined manner,” subject to …
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 …
Apr 25, 2024 · (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies'...
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 ... - U.S. News
Apr 25, 2024 · (Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies'...